Therapeutic areas

Nova's non small cell lung cancer (NSCLC) disease model of epidermal growth factor receptor (EGFR) mutant lung adenocarcinoma (LUAD)

Nova’s hepatitis B disease (HBV) model accounts for the virus pathophysiology, including viral replication within hepatocytes and antiviral immune response in chronically infected patients.